ChinaBio Today -- At ChinaBio® Today, we kicked off last week with an in-depth look at 2008’s venture capital investments in China’s life science industry (see story). The full-year numbers show a relatively small 16% falloff from 2007’s record investment pace, despite the worldwide economic collapse. However, full-year 2008’s numbers are distorted by a very strong Q1, followed by three quarters in which 2008’s activity was substantially below the year earlier. The venture capital review is part of our series “The State of China Biotech.” Earlier we presented research on life science patents since 2000, and we have a review of deals, both partnering and merger, still to come.
